The Joshua Arbesman lab studies genetic mechanisms that place patients at high risk for melanoma development.
The Shideng Bao lab studies glioma stem cell signaling pathways in malignant brain tumors, including glioblastoma.
The Abhishek Chakraborty lab studies oxygen loss and processes oxygen-deprived cancer cells employ for survival.
Dr. Peiwen Chen’s lab studies biological and molecular processes related to primary and metastatic brain cancers.
The Shuyang Chen lab has primary research interests in the environmental and genetic factors contributing to melanoma development.
The Candece Gladson lab investigates blocking angiogenesis and key molecules that promote survival in malignant glioma tumors.
The Zihua Gong lab studies molecular mechanisms underlying DNA repair pathway choice in breast and ovarian cancers.
The Khaled Hassan lab is studying lung cancer development and progression as well as mechanisms of resistance to its treatment.
The Hannelore Heemers lab explores drug targets for novel, prostate cancer-selective forms of androgen deprivation therapy.
The Ruth Keri Lab studies breast cancer, focusing on molecularly understanding mammary morphogenesis and carcinogenesis.
The Jeongwu Lee lab studies glioblastoma, focusing on cancer progression and treatment resistance.
The Brian Rubin lab studies the pathogenesis of bone and soft tissue cancers, collectively known as sarcomas.
The George Stark lab studies the complex cell signaling mechanisms underlying innate immunity and cancer.
The Jennifer Yu lab studies glioblastoma and mechanisms underlying stem cell maintenance and therapeutic resistance.
The Jianjun Zhao lab investigates deregulated coding and noncoding genes in the initiation of multiple myeloma.